Search bioRxiv⌕ Search

Biology subjects

Dayal, A.

Publications and source records attributed to Dayal, A..

2 recordsLinked to original sources

Lung Mycobacterium tuberculosis infection perturbs metabolic pathways in non-pulmonary tissues

Mycobacterium tuberculosis (Mtb), through aerosol, reaches the lungs to cause pulmonary tuberculosis (TB); however, it may also affect the metabolism of other tissues in age-specific ways. In this study, female C57BL/6 mice (2 and 5 months old; M) were infected with a low aerosol dose (100-200 cfu) of Mtb H37Rv to monitor tissue mycobacterial load and multi-tissue metabolite profiling using gas chromatography and mass spectrometry (GC-MS). 5M C57BL/6 mice showed separate tissue metabolic phenotype with significantly higher lung aspartic acid, fecal oxalic acid and tryptophan levels with lower liver lysine and aspartic acid and fecal phenylalanine levels (log2FC: 5M/2M> {+/-}1.0, p<0.1) compared to 2M young controls. Upon Mtb infection, the lung mycobacterial load of 2M and 5M mice were similar till 6 weeks post-infection. However, significantly higher lung phosphoric acid, malonic acid and lower mannose levels (log2FC: Mtb infected/healthy> {+/-}1.0, p<0.1) were observed in Mtb-infected 5M C57BL/6 mice. Meanwhile, Mtb-infected 2M mice showed higher liver xylose and lower lysine levels. The thigh muscles of Mtb-infected 2M and 5M mice showed increased malic acid and oxalic acid and decreased glycine, serine, and glycerol levels. Fecal aspartic acid level was higher in Mtb-infected 5M mice, while a decreased abundance of fecal lysine was observed in Mtb-infected 2M mice. Overall, this study demonstrates a deregulated tissue-specific amino acid metabolism in Mtb-infected mice groups of different age groups, which might be targeted for managing TB infection-related adverse effects.

biochemistry↗

The mechanism underlying transient weakness in myotonia congenita

In addition to the hallmark muscle stiffness, patients with recessive myotonia congenita (Becker disease) experience debilitating bouts of transient weakness that remain poorly understood despite years of study. We made intracellular recordings from muscle of both genetic and pharmacologic mouse models of Becker disease to identify the mechanism underlying transient weakness. Our recordings reveal transient depolarizations (plateau potentials) of the membrane potential to -25 to -35 mV in the genetic and pharmacologic models of Becker disease. Both Na+ and Ca2+ currents contribute to plateau potentials. Na+ persistent inward current (NaPIC) through Na{gamma}1.4 channels is the key trigger of plateau potentials and current through Cav1.1 Ca2+ channels contributes to the duration of the plateau. Inhibiting NaPIC with ranolazine prevents the development of plateau potentials and eliminates transient weakness in vivo. These data suggest that targeting NaPIC may be an effective treatment to prevent transient weakness in myotonia congenita. Impact StatementTransient weakness in myotonia congenita is caused by depolarization secondary to activation of persistent Na+ current in skeletal muscle.

physiology↗